Ensysce Biosciences, Inc. (ENSC) Operating margin 2020–2025
Ensysce Biosciences, Inc. (ENSC) operating margin by fiscal year — reported operating income divided by reported revenue.
-202.1%FY2025 · since FY2020: -41.0% → -202.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -202.1% | -72.9 pp |
| FY2024 | -129.2% | +351.3 pp |
| FY2023 | -480.5% | +479.4 pp |
| FY2022 | -959.9% | -397.2 pp |
| FY2021 | -562.7% | -521.7 pp |
| FY2020 | -41.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice